Clincosm LogoSign in Get a demo

leukemia

Showing NaN - NaN of 101
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cognitive Aftereffects of Neurotoxicity in Children and Young

Not yet recruiting
  • Lymphoma
  • Leukemia
    • Los Angeles, California
    • +2 more
    Feb 2, 2023

    Leukemia, Lymphoma Trial in United States (SCRI-CAR22v2)

    Recruiting
    • Leukemia
    • Lymphoma
    • SCRI-CAR22v2
    • Los Angeles, California
    • +4 more
    Jan 18, 2023

    Clinical Stage I Cutaneous Melanoma AJCC v8, Clinical Stage IA Cutaneous Melanoma AJCC v8, Clinical Stage IB Cutaneous Melanoma

    Recruiting
    • Clinical Stage I Cutaneous Melanoma AJCC v8
    • +33 more
    • Informational Intervention
    • +4 more
    • Los Angeles, California
    • +4 more
    Dec 14, 2022

    Cancer, Cancer Metastatic, Tumors Trial in Los Angeles (Virtual group based physical activity (BurnAlong) and Social Media

    Recruiting
    • Cancer
    • +21 more
    • Virtual group based physical activity (BurnAlong) and Social Media Discussion Board
    • Los Angeles, California
      Cedars-Sinai Medical Center
    Dec 7, 2022

    Leukemia Trial in Canada, Puerto Rico, United States (Ruxolitinib, Asparaginase Erwinia Chrysanthemi, Cyclophosphamide)

    Recruiting
    • Leukemia
    • Birmingham, Alabama
    • +109 more
    Aug 11, 2022

    Collecting and Storing Tissue From Young Patients With Cancer

    Recruiting
    • Acute Lymphoblastic Leukemia
    • +13 more
    • Cytology Specimen Collection Procedure
    • Laboratory Biomarker Analysis
    • Birmingham, Alabama
    • +68 more
    Aug 4, 2022

    Hematopoietic and Lymphoid System Tumor, Leukemia, Lymphoma Trial in Canada, United States (procedure, biological, other)

    Active, not recruiting
    • Hematopoietic and Lymphoid System Neoplasm
    • +3 more
    • Allogeneic Hematopoietic Stem Cell Transplantation
    • +3 more
    • Birmingham, Alabama
    • +42 more
    Jul 20, 2022

    Leukemia, Lymphoma Trial in Canada, United States (Patient-derived CD19- and CD22 specific CAR)

    Recruiting
    • Leukemia
    • Lymphoma
    • Patient-derived CD19- and CD22 specific CAR
    • Los Angeles, California
    • +4 more
    Apr 2, 2022

    Leukemia, Precursor b-Cell Lymphoblastic Leukemia-Lymphoma, ACUTE LYMPHOBLASTIC LEUKEMIA Trial in Worldwide (inotuzumab

    Active, not recruiting
    • Leukemia
    • +2 more
    • inotuzumab ozogamicin-dose level 2
    • Inotuzumab ozogamicin-dose level 1
    • Los Angeles, California
    • +45 more
    Mar 9, 2022

    Cancer, Cancer Metastatic, Tumors Trial in Los Angeles (Elly Mobile Phone Application)

    Recruiting
    • Cancer
    • +22 more
    • Elly Mobile Phone Application
    • Los Angeles, California
      Cedars Sinai Medical Center
    Dec 7, 2021

    Leukemia Trial in Worldwide (BMS-936564, Cytarabine)

    Terminated
    Has Results
    • Leukemia
    • Los Angeles, California
    • +37 more
    Aug 18, 2021

    Leukemia Trial in Canada, United States (troxacitabine)

    Completed
    • Leukemia
    • Duarte, California
    • +19 more
    Jun 7, 2021

    Leukemia, Lymphoma, GVHD Trial in Australia, United States (cyclosporine, cyclosporine and methotrexate)

    Terminated
    • Leukemia
    • +2 more
    • Los Angeles, California
    • +12 more
    May 3, 2021

    Leukemia Trial in Worldwide (asparaginase, cytarabine, daunorubicin HCl)

    Completed
    Has Results
    • Leukemia
    • Birmingham, Alabama
    • +197 more
    Mar 22, 2021

    Breast Carcinoma, Cancer Survivor, Depression Trial in United States (procedure, other, behavioral)

    Completed
    • Breast Carcinoma
    • +12 more
    • Management of Therapy Complications
    • +3 more
    • Los Angeles, California
    • +5 more
    Oct 8, 2020

    Leukemia, MDS, Myelodysplastic/Myeloproliferative Tumors Trial in United States (arsenic trioxide)

    Terminated
    • Leukemia
    • +2 more
    • arsenic trioxide
    • Tucson, Arizona
    • +7 more
    Oct 2, 2020

    Cervical Cancer, Chronic Myeloproliferative Disorders, Leukemia Trial in Los Angeles (Fragmin, )

    Completed
    • Cervical Cancer
    • +8 more
    • Los Angeles, California
      Jonsson Comprehensive Cancer Center, UCLA
    Jul 30, 2020

    Anemia, Leukemia, Lymphoma Trial in Los Angeles (darbepoetin alfa, epoetin alfa)

    Completed
    • Anemia
    • +6 more
    • darbepoetin alfa
    • epoetin alfa
    • Los Angeles, California
      Jonsson Comprehensive Cancer Center, UCLA
    Jul 30, 2020

    Leukemia Trial in Los Angeles (dasatinib)

    Completed
    • Leukemia
    • Los Angeles, California
      Jonsson Comprehensive Cancer Center at UCLA
    Jul 30, 2020

    Leukemia, MDS Trial in Los Angeles (arsenic trioxide, azacitidine)

    Terminated
    • Leukemia
    • Myelodysplastic Syndromes
    • Los Angeles, California
      Jonsson Comprehensive Cancer Center at UCLA
    Jul 29, 2020

    Leukemia, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia Trial in Canada, United States (EPZ-5676)

    Completed
    • Leukemia
    • +3 more
    • Los Angeles, California
    • +8 more
    May 7, 2020

    Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Tumor Trial in United States (biological, drug, procedure, radiation)

    Withdrawn
    • Leukemia
    • +4 more
    • alemtuzumab
    • +6 more
    • La Jolla, California
    • +23 more
    Nov 25, 2019

    Leukemia, Myeloid, Leukemia, Acute Myeloid Leukemia (AML) Trial in United States (procedure, drug, radiation)

    Terminated
    Has Results
    • Leukemia, Myeloid
    • +2 more
    • Allogeneic HSCT
    • +6 more
    • Hayward, California
    • +4 more
    Sep 11, 2019

    Leukemia, MDS Trial in United States (biological, drug, procedure, radiation)

    Completed
    • Leukemia
    • Myelodysplastic Syndromes
    • anti-thymocyte globulin
    • +7 more
    • Los Angeles, California
    • +5 more
    Jul 1, 2019

    Leukemia Trial in Worldwide (Midostaurin (PKC412))

    Completed
    Has Results
    • Leukemia
    • Midostaurin (PKC412)
    • Los Angeles, California
    • +28 more
    Oct 16, 2018